HTLV-1: Clinical Trials

1 trial for HTLV-1, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow HTLV-1: new trials by email Literature Review of HTLV-1 trials Research Report on HTLV-1

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Hu Mik-Beta-1 to Treat HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
Hu MiK-Beta-1 - HTLV-1
Phase 1CompletedNational Institute of Neurological Disorders and Stroke (NINDS)92004-02-032019-06-27

Narrower conditions

Paraparesis, Tropical Spastic (1)

Broader conditions

Central Nervous System Diseases (1)  ·  Central Nervous System Infections (1)  ·  Deltaretrovirus Infections (1)  ·  HTLV-I Infections (1)  ·  Infections (1)  ·  Myelitis (1)  ·  Nervous System Diseases (1)  ·  Neuroinflammatory Diseases (1)  ·  RNA Virus Infections (1)  ·  Retroviridae Infections (1)  ·  Spinal Cord Diseases (1)  ·  Virus Diseases (1)

Interventions

Hu-Mik-beta-1 monoclonal antibody (1)

Sponsors

National Institute of Neurological Disorders and Stroke (NINDS) (1)

Countries

United States (1)

Top investigators

Steven Jacobson, Ph.D. (1)